Induction of sister chromatid exchanges by pyrimethamine in human lymphocyte cultures

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 18, Issue 4, 1998, Pages 163-169

  Egeli, Ünal ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Genotoxicity; Human lymphocyte culture; Pyrimethamine; Sister chromatid exchanges; Toxoplasmosis

Indexed keywords

FOLIC ACID ANTAGONIST; PYRIMETHAMINE;

ARTICLE; CARCINOGENICITY; CYTOGENETICS; DNA REPLICATION; DRUG EFFECT; ENZYME INHIBITION; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MUTAGENICITY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN INDUCTION; SISTER CHROMATID EXCHANGE; TOXOPLASMOSIS;

ADULT; ANTIPROTOZOAL AGENTS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LYMPHOCYTES; MALE; PYRIMETHAMINE; SISTER CHROMATID EXCHANGE;

EID: 0031768395     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(1998)18:4<163::AID-TCM2>3.0.CO;2-L     Document Type: Article

References (39)

1. Dipelma J: Chemotherapy of protozoon infections. I. Malari. In Dipelma J: "Drill's Pharmacology in Medicine." 4th Ed. New York: McGraw-Hill, 1971, pp 1770-1789.
2. Meyers HF, Jawetz E, Goldfien A: "Review of Medical Pharmacology." 4th Ed. Los Altos, CA, 1974.
3. Webster TL: Drugs used in the chemotherapy of protozoal infections. In Gilman AG, Murad F: "The Pharmacological Basis of Therapeutics." 8th Ed. New York: Macmillan, 1985, pp 1035-1037.
4. Ono Y, Norimatsu M, Yashimura H: Induction of chromosome aberrations by pyrimethamine in cultured Chinese hamster (CHL) cells. Mutat Res 323:197-201, 1994.
5. Harpey JP, Darbois Y, Lefebure G: Teratogenicity of pyrimethamine. Lancet 399:1983.
6. Smithells RW, Sheppard S: Teratogenicity of debendox and pyrimethamine. Lancet 623-624, 1983.
7. Tangapregassom AM, Tangapregassom MJ, Horwath C, Trecul M, Boucher-Ehrensberger M, Petter C: Vascular anomalies and pyrimethamine-induced malformations in the rat. Teratogen Carcinog Mutagen 5:55-62, 1985.
8. Cimino MC, Tice RR, Liang JC: Aneuploidy in mammalian somatic cells in vivo. Mutat Res 167:107-122, 1986.
9. Adler ID, Kliesch U, van Hummelen P, Kirsch-Volders M: Mouse micronucleus test with known and suspect spindle poisons: Results from two laboratories. Mutagenesis 6:47-53, 1991.
10. Lynch AM, Parry JM: The cytochalasin-B micronucleus/kinetochore assay in vitro: Studies with 10 suspected aneugens. Mutat Res 287:71-86, 1993.
11. Warr TJ, Parry EM, Parry JM: A comparison of two in vitro mammalian cell cytogenetic assays for the detection of mitotic aneuploidy using 10 known or suspected aneugens. Mutat Res 287:29-46, 1993.
12. Ono T, Yashimura H: Analysis of micronucleus induction of pyrimethamine in in vitro CHL cells and in in vivo mouse bone marrow cells. Mutagenesis 11:85-87, 1996.
13. Ohta T, Mosiya M, Kaneda Y, Watanabe K, Miyazawa T, Sugiyama F, Shirasu Y: Mutagenicity screening of feed additives in microbial system. Mutat Res 77:21-30, 1980.
14. Rhee JC, Lee KJ, Namgoong S, Park KS: Mutagenical evaluation of animal-drug by using Chinese hamster lung cell. Res Rep Rural Dev Admin 31:45-51, 1989.
15. Egeli Ü, Erdogan G: The clastogenic effect of pyrimethamine (Daraprim) of human chromosomes in lymphocyte cultures. Cell Biol Toxicol 7:347-356, 1991.
16. Egeli Ü, Tunca B: Detection of fragile sites induced by pyrimethamine. Teratogen Carcinog Mutagen 17:59-69, 1997.
17. Latt SA: Sister chromatid exchange indices of human chromosome damage and repair: Detection by floor and induction by mitomycin C. Proc Natl Acad Sci USA 71:3162-3166, 1974.
18. Sasiadek M, Norppa H, Sorsa M: 1,3-Butadiene and its epoxides induce sister chromatid exchanges in human lymphocytes in vitro. Mutat Res 261:117-121, 1991.
19. Lanbert B, Lindblad A, Nordenskjold B, Werelius B: Increased frequency of sister chromatid exchanges in cigarette smokers. Hereditas 88:147-149, 1978.
20. Camurri L, Codeluppi S, Pedroni C, Scarduelli L: Chromosomal aberrations and sister chromatid exchanges in workers exposed to styrene. Mutat Res 119:361-369, 1983.
21. Jong G, van Sittert NJ, Natarajen AT: Cytogenetic monitoring of industrial populations potentially exposed to genotoxic chemicals and of control populations. Mutat Res 204:451-464, 1988.
22. Latt SA, Schereck RR: Sister chromatid exchange analysis. Am J Hum Genet 32:297-313, 1980.
23. Tucker JD, Auletta A, Cimino MC, Desifield KL, Jacobson-Kram D, Tice RR, Carrano AV: Sister chromatid exchange, second report of gene-tox program. Mutat Res 297:101-180, 1993.
24. Carrano AV, Thampson LM, Lindl PA, Minkler JL: Sister chromatid exchange as an indicator of mutagenesis. Nature 271:551-553, 1978.
25. Waxman S, Herbert V: Mechanism of pyrimethamine induced megaloblastosis in human bone marrow. N Engl J Med 280:1316-1319, 1969.
26. Dyke VK: "Antimalarial Drugs." New York: Little, Brown 1982.
27. Glower WT, Stein CK: Chromosome breakage and recombination at fragile sites. Am J Hum Genet 43:265-273, 1988.
28. Fundai AF, Larippa IB: Coincidence in fragile site expression with fluorodeoxyuridine and bromodeoxyuridine. Cancer Genet Cytogenet 41:41-48, 1989.
29. Yunis JJ: The chromosomal basis of human neoplasia. Science 221:227-236, 1983.
30. Le Beau MM, Rowley JD: Heritable fragile sites in cancer. Nature 308:607-608, 1984.
31. Yunis JJ: Fragile sites and predisposition to leukemia and lymphoma. Cancer Genet Cytogenet 12:85-88, 1984.
32. De Brackeler M, Smith B, Lin CC: Fragile sites and structural rearrangements in cancer. Hum Genet 69:112-116, 1985.
33. Le Beau MM: Chromosomal fragile sites and cancer specific rearrangements. Blood 67:849-858, 1986.
34. Sozzi G, Veronose MY, Negrini M, Baffa R, Coticelli MG, Inoue H, Tornielli S, et al.: The FHIT gene at 3p14.2 is abnormal in lung cancer 85:17-26, 1996.
35. Egeli Ü, Karadag M, Tunca B, Ozyardimci N: The expression of common fragile sites and genetic predisposition to squamous cell lung cancers. Cancer Genet Cytogenet 20:1-6, 1997.
36. Tunca B, Egeli Ü, Zorluoglu A, Yilmazlar T, Kizil A: Expression of fragile sites in lymphocytes of colon cancer patients and their relatives. NATO Advanced Study Institute. "DNA Damage and Repair: Oxygen Radical Effects, Cellular Protection and Biological Consequences." Abstract Book. Antalya, Turkey, October 14-24, 1997, p. 122.
37. Zorluoglu A, Tunca B, Egeli Ü, Yilmazlar T, Kizil A: "The Expression of Fragile Sites and Genetic Predisposition to Rectum Cancers." 37th World Congress of Surgery of the ISS/SIC, Abstract Book. Acapulco, Mexico, August 24-30, 1997, p. 108.
38. Hori T: "Molecular Cytogenetic Studies on Chromosomal Fragile Sites." 10th International Congress on Radiation Research, Congress Lectures. Würzburg, Germany, August 27-September 1, 1995, pp 464-467.
39. Egeli Ü, Erdogan G: The effect of pyrimethamine on human lymphocyte chromosomes used during toxoplasmosis therapy. J Med Fac Uludag Univ 1(18): 19-27, 1991.